Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients
Clinical trial NCT01103414 · COMPLETED
Trial details
- NCT number
- NCT01103414
- Sponsor
- Metabolic Solutions Development Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-11-01
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.